TherapeuticsMD Announces FDA Approval of TX-004HR: IMVEXXY (estradiol vaginal inserts), the Lowest Dose Vaginal Estrogen Product Approved for the Treatment of Moderate to Severe Dyspareunia, a Symptom
Go back to TherapeuticsMD Announces FDA Approval of TX-004HR: IMVEXXY (estradiol vaginal inserts), the Lowest Dose Vaginal Estrogen Product Approved for the Treatment of Moderate to Severe Dyspareunia, a Symptom| THERAPEUTICSMD, Inc. (NASDAQ: TXMD) | Delayed: 2.20 +0.38 (20.88%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.82 | 52 Week High | $11.26 | |||
| Open | $1.85 | 52 Week Low | $4.39 | |||
| Day High | $2.20 | P/E | N/A | |||
| Day Low | $1.85 | EPS | $-0.22 | |||
| Volume | 259,965 | |||||
